cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.25549/inscriptifact-ouc110594668
title: Persepolis Fortification Anepigraphic Tablet 0845.104, PFAnep 0845.104

description: [Text Description:] Administrative text with seals PFUTS 0041; PFUTS 0042s ❧ [Text or Publication Number Note:] PFAnep 0845.104, PFUT 0845-104 ❧ [Excavation Description:] Found during Oriental Institute's excavations in Spring, 1933, near the northeastern corner of the stone platform of Persepolis, in two small rooms of a bastion in the fortification wall ❧ [Medium:] Clay ❧ [Script Note:] Non-Text ❧ [Physical Object Description:] Clay tablet with seal impressions PFUTS 0041 on obverse; PFUTS 0042s on left edge.
DOI: 10.25549/jrbm-ouc16326507
title: 七不思儀葛飾物語 / 柳亭種彦述 ; [梅蝶樓]國貞畫 [volume 2]

description: On double leaves, oriental style (fukurotoji). Fiction.
DOI: 10.25549/inscriptifact-ouc110594130
title: Persepolis Fortification Anepigraphic Tablet 0688.101, PFAnep 0688.101

description: [Text Description:] Administrative text with seal PFUTS 0082s ❧ [Text or Publication Number Note:] PFAnep 0688.101, PFUT 0688-101 ❧ [Excavation Description:] Found during Oriental Institute's excavations in Spring, 1933, near the northeastern corner of the stone platform of Persepolis, in two small rooms of a bastion in the fortification wall ❧ [Medium:] Clay ❧ [Script Note:] Non-Text ❧ [Physical Object Description:] Clay tablet with seal impression PFUTS 0082s on obverse.
DOI: 10.25549/inscriptifact-ouc110597659
title: Persepolis Fortification Aramaic Text 390, PFAT 390

description: [Text Description:] Administrative text with seal PFUTS 0019*. ❧ [Text or Publication Number Note:] PFAT 390, Bowman 390 ❧ [Excavation Description:] Found during Oriental Institute's excavations in Spring, 1933, near the northeastern corner of the stone platform of Persepolis, in two small rooms of a bastion in the fortification wall ❧ [Medium:] Clay ❧ [Script Note:] Aramaic ❧ [Physical Object Description:] Clay tablet with ink inscription. Seal impression PFUTS 0019* on obverse, upper edge, reverse, bottom edge, flat edge.
DOI: 10.25549/jrbm-ouc16326506
title: 七不思儀葛飾物語 / 柳亭種彦述 ; [梅蝶樓]國貞畫 [volume 2]

description: On double leaves, oriental style (fukurotoji). Fiction.
DOI: 10.25549/inscriptifact-ouc110597655
title: Persepolis Fortification Aramaic Text 389, PFAT 389

description: [Text Description:] Administrative text with seal PFATS 0378. ❧ [Text or Publication Number Note:] PFAT 389, Bowman 389 ❧ [Excavation Description:] Found during Oriental Institute's excavations in Spring, 1933, near the northeastern corner of the stone platform of Persepolis, in two small rooms of a bastion in the fortification wall ❧ [Medium:] Clay ❧ [Script Note:] Aramaic ❧ [Physical Object Description:] Clay tablet with ink inscription. Seal impression PFATS 0378 on obverse, upper edge, reverse, bottom edge, flat edge.
DOI: 10.25549/inscriptifact-ouc110594127
title: Persepolis Fortification Anepigraphic Tablet 0688.101, PFAnep 0688.101

description: [Text Description:] Administrative text with seal PFUTS 0082s ❧ [Text or Publication Number Note:] PFAnep 0688.101, PFUT 0688-101 ❧ [Excavation Description:] Found during Oriental Institute's excavations in Spring, 1933, near the northeastern corner of the stone platform of Persepolis, in two small rooms of a bastion in the fortification wall ❧ [Medium:] Clay ❧ [Script Note:] Non-Text ❧ [Physical Object Description:] Clay tablet with seal impression PFUTS 0082s on obverse.
DOI: 10.25549/jrbm-ouc16326505
title: 七不思儀葛飾物語 / 柳亭種彦述 ; [梅蝶樓]國貞畫 [volume 2]

description: On double leaves, oriental style (fukurotoji). Fiction.
DOI: 10.25549/inscriptifact-ouc110594123
title: Persepolis Fortification Anepigraphic Tablet 0688.101, PFAnep 0688.101

description: [Text Description:] Administrative text with seal PFUTS 0082s ❧ [Text or Publication Number Note:] PFAnep 0688.101, PFUT 0688-101 ❧ [Excavation Description:] Found during Oriental Institute's excavations in Spring, 1933, near the northeastern corner of the stone platform of Persepolis, in two small rooms of a bastion in the fortification wall ❧ [Medium:] Clay ❧ [Script Note:] Non-Text ❧ [Physical Object Description:] Clay tablet with seal impression PFUTS 0082s on obverse.
DOI: 10.25549/inscriptifact-ouc110597631
title: Persepolis Fortification Aramaic Text 389, PFAT 389

description: [Text Description:] Administrative text with seal PFATS 0378. ❧ [Text or Publication Number Note:] PFAT 389, Bowman 389 ❧ [Excavation Description:] Found during Oriental Institute's excavations in Spring, 1933, near the northeastern corner of the stone platform of Persepolis, in two small rooms of a bastion in the fortification wall ❧ [Medium:] Clay ❧ [Script Note:] Aramaic ❧ [Physical Object Description:] Clay tablet with ink inscription. Seal impression PFATS 0378 on obverse, upper edge, reverse, bottom edge, flat edge.
DOI: 10.25549/jrbm-ouc16326503
title: 七不思儀葛飾物語 / 柳亭種彦述 ; [梅蝶樓]國貞畫 [volume 2]

description: On double leaves, oriental style (fukurotoji). Fiction.
DOI: 10.25549/inscriptifact-ouc1sto1607691
title: InscriptiFact -- an image database of inscriptions and artifacts

description: The InscriptiFact Collection is designed to allow access via the Internet to high-resolution images of ancient inscriptions and artifacts, primarily from the Near Eastern and Mediterranean Worlds. The targeted inscriptions constitute some of the world’s earliest written records, which are mostly housed in a number of international museums and libraries, as well as field projects where inscriptions still remain in situ. Included, for example, are, selected Dead Sea Scrolls; cuneiform tablets from Mesopotamia, Persia, Canaan and Egypt; early Jewish papyri from Egypt; lapidary inscriptions, primarily from Jordan, Lebanon and Cyprus; inscriptions on a variety of hard media (e.g., ostraca, copper, semi-precious stones, jar handles) mostly written in early Canaanite, Phoenician, Hebrew, Aramaic, Ammonite and Edomite; and much more. These ancient texts are foundational documents that serve as a point of reference for Judaism, Christianity, Islam and the cultures out of which they emerged. The name "InscriptiFact" is intended to convey the concept of a scholarly archive based on "facts" about "inscriptions" and "artifacts." West Semitic Research Project (WSRP) under the auspices of the University of Southern California (USC) is broadly acknowledged as a leader in the application of photographic and digital technologies to capture and analyze data of ancient texts. The West Semitic Research image archive now contains approximately 1,500,000 images. Important! Search terms with more than one word or number need to be enclosed in quotation marks.Guide to Searching InscriptiFact
DOI: 10.25549/inscriptifact-ouc110594122
title: Persepolis Fortification Anepigraphic Tablet 0688.101, PFAnep 0688.101

description: [Text Description:] Administrative text with seal PFUTS 0082s ❧ [Text or Publication Number Note:] PFAnep 0688.101, PFUT 0688-101 ❧ [Excavation Description:] Found during Oriental Institute's excavations in Spring, 1933, near the northeastern corner of the stone platform of Persepolis, in two small rooms of a bastion in the fortification wall ❧ [Medium:] Clay ❧ [Script Note:] Non-Text ❧ [Physical Object Description:] Clay tablet with seal impression PFUTS 0082s on obverse.
DOI: 10.25549/jrbm-ouc16326502
title: 七不思儀葛飾物語 / 柳亭種彦述 ; [梅蝶樓]國貞畫 [volume 2]

description: On double leaves, oriental style (fukurotoji). Fiction.
DOI: 10.25549/inscriptifact-ouc110594634
title: Persepolis Fortification Anepigraphic Tablet 0844.104, PFAnep 0844.104

description: [Text Description:] Administrative text with seal PFUTS 0017 ❧ [Text or Publication Number Note:] PFAnep 0844.104, PFUT 0844-104 ❧ [Excavation Description:] Found during Oriental Institute's excavations in Spring, 1933, near the northeastern corner of the stone platform of Persepolis, in two small rooms of a bastion in the fortification wall ❧ [Medium:] Clay ❧ [Script Note:] Non-Text ❧ [Physical Object Description:] Clay tablet with seal impression PFUTS 0017 on obverse, upper edge, reverse, bottom edge, left edge, right edge.
DOI: 10.48567/kemw-v023
title: Elizabeth Automatic Weather Station, 2007 quality-controlled observational data.
DOI: 10.48567/vd3k-mk80
title: Emilia Automatic Weather Station, 2007 quality-controlled observational data.
DOI: 10.34740/kaggle/dsv/11970790
title: Human Epithelial Cell Chromosomes Colorized
DOI: 10.15468/dl.pt2ckw
title: Occurrence Download

description: A dataset containing 1 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Country is Peru",
 "TaxonKey is Telmatobius arequipensis Vellard, 1955",
 "Year 2005-2015"
 ]
}

 The dataset includes 1 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0004983-250525065834625/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.sjpa5n
title: Occurrence Download

description: A dataset containing 8 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Oxalis debilis",
 "Country is Malaysia",
 "HasCoordinate is true"
 ]
}

 The dataset includes 8 records from 2 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0081609-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.5281/zenodo.18210544
title: Code and Data_EnergyModelComparison_V1
DOI: 10.5281/zenodo.18210545
title: Code and Data_EnergyModelComparison_V1
DOI: 10.15468/dl.xwgmkp
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{"type":"and","predicates":[{"type":"equals","key":"GADM_LEVEL_2_GID","value":"TUR.56.3_1","matchCase":false},{"type":"equals","key":"CLASS_KEY","value":"212","matchCase":false},{"type":"greaterThanOrEquals","key":"YEAR","value":"2015","matchCase":false},{"type":"not","predicate":{"type":"in","key":"BASIS_OF_RECORD","values":["MATERIAL_CITATION","MATERIAL_SAMPLE","PRESERVED_SPECIMEN"],"matchCase":false}},{"type":"lessThanOrEquals","key":"COORDINATE_UNCERTAINTY_IN_METERS","value":"10000","matchCase":false},{"type":"equals","key":"LICENSE","value":"CC BY 4.0","matchCase":false}]}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007041-260108223611665/datasets/export for details.
DOI: 10.15468/dl.vbs3x3
title: Occurrence Download

description: A dataset containing 1122 species occurrences available in GBIF matching the query:
{"type":"and","predicates":[{"type":"equals","key":"GADM_LEVEL_2_GID","value":"USA.1.2_1","matchCase":false},{"type":"equals","key":"CLASS_KEY","value":"212","matchCase":false},{"type":"greaterThanOrEquals","key":"YEAR","value":"2015","matchCase":false},{"type":"not","predicate":{"type":"in","key":"BASIS_OF_RECORD","values":["MATERIAL_CITATION","MATERIAL_SAMPLE","PRESERVED_SPECIMEN"],"matchCase":false}},{"type":"lessThanOrEquals","key":"COORDINATE_UNCERTAINTY_IN_METERS","value":"10000","matchCase":false},{"type":"equals","key":"LICENSE","value":"CC BY 4.0","matchCase":false}]}

 The dataset includes 1122 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0007040-260108223611665/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.cnwvsb
title: Occurrence Download

description: A dataset containing 6228 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Arses kaupi)",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 "License is one of (CC-BY 4.0, CC0 1.0)"
 ]
}

 The dataset includes 6228 records from 19 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0082724-250717081556266/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.u24drs
title: Occurrence Download

description: A dataset containing 1 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is BOLD:ADL4130"
 ]
}

 The dataset includes 1 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0032215-250802193616735/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.6084/m9.figshare.29875220
title: Supplementary Material for: Efficacy of Neoadjuvant Hormone Therapy Combined with Radical Prostatectomy in Improving Oncological Outcomes for Patients with cT3 Prostate Cancer: A Systematic Review and Meta-Analysis

description: Introduction: Prostate cancer (PCa), especially at clinical stage T3 (cT3), leads to significant health issues and economic costs, highlighting the urgent need for improved treatment strategies. This systematic review and meta-analysis aimed to evaluate the efficacy of neoadjuvant hormone therapy (NHT) combined with radical prostatectomy (RP) in enhancing oncological outcomes for patients with cT3 PCa.
Methods: We systematically searched PubMed, Embase, the Cochrane Library, and Web of Science for studies published until May 17, 2025. Randomized controlled trials (RCTs) comparing RP alone versus RP with NHT in cT3 PCa patients were included. Primary outcomes were positive surgical margin (PSM) rates and prostate-specific antigen progression-free survival (PSA-PFS). Pooled risk ratios (RR) and mean differences (MD) with 95% confidence intervals (CI) were calculated using fixed- or random-effects models, depending on heterogeneity.
Results: From 9,800 screened records, 10 RCTs were included in the meta-analysis. NHT combined with RP significantly reduced PSM rates (RR=0.75, 95% CI: 0.60–0.94, P=0.01), with improved results noted in patients who received 6 months or more of NHT (RR=0.75, P=0.01). Subgroup analysis revealed pronounced benefits in Asian populations (RR=0.47, P=0.001), whereas North American cohorts showed non-significant trends (RR=0.87, P=0.18). Subgroup analysis showed significant benefits for Asian populations (RR=0.47, P=0.001), while North American groups exhibited trends that were not statistically significant (RR=0.87, P=0.18). NHT combined with RP demonstrated a modest but significant improvement in PSA-PFS (MD=1.60 months, 95% CI: 0.47–2.73, P=0.006), albeit with moderate heterogeneity (I²=65%). Sensitivity analyses and publication bias assessments (Egger’s P=0.599; Begg’s P=0.655) supported result robustness.
Conclusion: NHT in conjunction with RP significantly improves oncological outcomes, particularly regarding PSM and PSA-PFS. However, the long-term survival benefits are still unclear, indicating the need for further research.
DOI: 10.6084/m9.figshare.29875220.v1
title: Supplementary Material for: Efficacy of Neoadjuvant Hormone Therapy Combined with Radical Prostatectomy in Improving Oncological Outcomes for Patients with cT3 Prostate Cancer: A Systematic Review and Meta-Analysis

description: Introduction: Prostate cancer (PCa), especially at clinical stage T3 (cT3), leads to significant health issues and economic costs, highlighting the urgent need for improved treatment strategies. This systematic review and meta-analysis aimed to evaluate the efficacy of neoadjuvant hormone therapy (NHT) combined with radical prostatectomy (RP) in enhancing oncological outcomes for patients with cT3 PCa.
Methods: We systematically searched PubMed, Embase, the Cochrane Library, and Web of Science for studies published until May 17, 2025. Randomized controlled trials (RCTs) comparing RP alone versus RP with NHT in cT3 PCa patients were included. Primary outcomes were positive surgical margin (PSM) rates and prostate-specific antigen progression-free survival (PSA-PFS). Pooled risk ratios (RR) and mean differences (MD) with 95% confidence intervals (CI) were calculated using fixed- or random-effects models, depending on heterogeneity.
Results: From 9,800 screened records, 10 RCTs were included in the meta-analysis. NHT combined with RP significantly reduced PSM rates (RR=0.75, 95% CI: 0.60–0.94, P=0.01), with improved results noted in patients who received 6 months or more of NHT (RR=0.75, P=0.01). Subgroup analysis revealed pronounced benefits in Asian populations (RR=0.47, P=0.001), whereas North American cohorts showed non-significant trends (RR=0.87, P=0.18). Subgroup analysis showed significant benefits for Asian populations (RR=0.47, P=0.001), while North American groups exhibited trends that were not statistically significant (RR=0.87, P=0.18). NHT combined with RP demonstrated a modest but significant improvement in PSA-PFS (MD=1.60 months, 95% CI: 0.47–2.73, P=0.006), albeit with moderate heterogeneity (I²=65%). Sensitivity analyses and publication bias assessments (Egger’s P=0.599; Begg’s P=0.655) supported result robustness.
Conclusion: NHT in conjunction with RP significantly improves oncological outcomes, particularly regarding PSM and PSA-PFS. However, the long-term survival benefits are still unclear, indicating the need for further research.
DOI: 10.6084/m9.figshare.29875223
title: Supplementary Material for: French Translation and Validation of an Objective Swallowing Rating Scale: The PAS

description: Introduction: Oropharyngeal dysphagia is a severe swallowing disorder with consequences that can be life-threatening or impair quality of life. One of the major risks is laryngeal penetration, which can lead to the bolus being aspirated. It is best assessed and quantified using The Penetration Aspiration Scale (PAS), which is a validated tool in English. Our aim was to translate in French and validate the French version of the Penetration-Aspiration Scale (Fr-PAS). Methods: Our study was two fold i) to assess the contribution of the Fr-PAS for French-speaking speech-language therapists (SLT) in their management of dysphagic patients using a survey questionnaire, ii) to translate the scale and to perform linguistic and psychometric validation of the Fr-PAS and its reliability by assessing 64 video sequences from patients with oropharyngeal dysphagia using Fiberoptic Endoscopic Evaluations of Swallowing (FEES). Intrarater reliability was assessed using a 15-day test-retest procedure by Kendall tau. Interrater reliability was evaluated using Cronbach’s alpha. Results: The survey demonstrated strong interest in the use of Fr-PAS, with 96.43 % 0f Speech Language Therapists providing positive responses. The Fr-PAS reported high internal consistency (α = 0.85) and reproducibility (𝛕 =0.8583 and p &lt;0.001). Conclusion: The French version of PAS is reliable and reproducible over time. The tool responds to a specific demand in assessing the severity of dysphagia and its management by SLT and the clinical team.
DOI: 10.6084/m9.figshare.29875223.v1
title: Supplementary Material for: French Translation and Validation of an Objective Swallowing Rating Scale: The PAS

description: Introduction: Oropharyngeal dysphagia is a severe swallowing disorder with consequences that can be life-threatening or impair quality of life. One of the major risks is laryngeal penetration, which can lead to the bolus being aspirated. It is best assessed and quantified using The Penetration Aspiration Scale (PAS), which is a validated tool in English. Our aim was to translate in French and validate the French version of the Penetration-Aspiration Scale (Fr-PAS). Methods: Our study was two fold i) to assess the contribution of the Fr-PAS for French-speaking speech-language therapists (SLT) in their management of dysphagic patients using a survey questionnaire, ii) to translate the scale and to perform linguistic and psychometric validation of the Fr-PAS and its reliability by assessing 64 video sequences from patients with oropharyngeal dysphagia using Fiberoptic Endoscopic Evaluations of Swallowing (FEES). Intrarater reliability was assessed using a 15-day test-retest procedure by Kendall tau. Interrater reliability was evaluated using Cronbach’s alpha. Results: The survey demonstrated strong interest in the use of Fr-PAS, with 96.43 % 0f Speech Language Therapists providing positive responses. The Fr-PAS reported high internal consistency (α = 0.85) and reproducibility (𝛕 =0.8583 and p &lt;0.001). Conclusion: The French version of PAS is reliable and reproducible over time. The tool responds to a specific demand in assessing the severity of dysphagia and its management by SLT and the clinical team.
DOI: 10.6084/m9.figshare.29875226
title: Supplementary Material for: Newly developed drugs for hepatocellular carcinoma expanded the use of systemic therapy: An interrupted time series analysis using an electronic medical record in Japan

description: Introduction: Systemic therapy options for hepatocellular carcinoma (HCC) have rapidly expanded, transforming the treatment landscape. However, real-world changes in treatment choices remain unclear. This study aimed to determine the current treatment choices for HCC in Japan considering age and liver functional reserves.
Methods: We conducted an interrupted time series analysis using electronic medical records in Japan to assess the overall changes in the proportions of systemic therapy among the initial treatments for HCC following the approval of lenvatinib in 2018 and atezolizumab plus bevacizumab (atezo/bev) in 2020, stratified by age and modified albumin-bilirubin (mALBI) grade. This study included patients who were diagnosed with HCC between 2015 and 2022. We also assessed 2-year survival rates.
Results: In the interrupted time series analysis, the proportions of systemic therapy among the initial treatments for HCC increased by 3.96% (95% confidence interval: 2.75, 5.17, p &lt; 0.001) following lenvatinib approval, with a 1.00% (0.45, 1.55, p = 0.002) slope change per 6 months. There was a 4.27% (1.69, 6.86, p = 0.004) increase in systemic therapy use following atezo/bev approval and a 0.27% (-0.66, 1.20, p = 0.53) slope change. In age subgroups with a cutoff of 75 years, the largest increase in systemic therapy use was 6.94% (4.46, 9.42) in the elderly group following atezo/bev approval (p = 0.189). Increases in systemic therapy use following lenvatinib approval in patients with mALBI grades 2b or 3 and 1 or 2 were 10.0% (6.70, 13.42) and 0.80% (-1.16, 2.77), respectively (p &lt; 0.001). There was no apparent change in the overall 2-year survival or in any subgroup before and after approval.
Conclusion: Newly developed drugs for HCC would expand the population for systemic therapy. The optimal population for systemic therapy should be explored based on long-term survival considering age and liver functional reserve heterogeneity.